Skip to main content

Table 1 Baseline characteristics

From: Stereotactic body radiation therapy (SBRT) for lung malignancies: preliminary toxicity results using a flattening filter-free linear accelerator operating at 2400 monitor units per minute

  Number of patients (%)
Histology  
Non-small cell lung cancer 56 (88%)
Other 6 (9%)
No pathology 2 (3%)
Dose schedule  
6 Gy × 5 fractions 2 (3%)
8 Gy × 5 fractions 7 (11%)
9 Gy × 5 fractions 1 (1.5%)
10 Gy × 5 fractions 10 (16%)
10.5 Gy × 5 fractions 7 (11%)
12 Gy × 4 fractions 17 (27%)
18 Gy* × 3 fractions 19 (29%)
Other 1 (1.5%)
Tumor size  
≤ 3 cm 36 (56%)
>3 cm 28 (44%)
SBRT indication  
Refused surgery 7 (11%)
Medically inoperable 47 (73%)
Surgically incurable 10 (16%)
Location  
Central 23 (36%
Peripheral 41 (64%)
  1. Baseline characteristics and treatment details for 64 evaluable patients treated with FFF lung SBRT.
  2. *Includes 20 Gy in 3 fractions without heterogeneity correction.